Skip to main content

Table 2 Expression of miR-216b-5p in serous epithelial ovarian cancer tissues

From: Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer

  

miR-216b-5p

  
 

Total cases

High expression (n = 37)

Low expression (n = 58)

χ2

P

 

n

n

%

n

%

  

Age (year)

     

0.074

0.786

Postmenopausal(< 50)

42

17

40.48

25

59.52

  

Premenopausal (50)

53

20

37.74

33

62.26

  

Tumor stage (FIGO)

     

2.708

0.258

I-II

21

8

38.10

13

61.90

  

III

45

21

46.67

24

53.33

  

IV

29

8

27.59

21

72.41

  

Histological grade (n = 88)

     

2.216

0.137

H

72

26

36.11

46

63.89

  

L

16

9

56.25

7

43.75

  

Nodal status (n)

     

2.509

0.113

Negative

60

27

45.00

33

55.00

  

Positive

35

10

28.57

25

71.43

  

Tumor diameter (cm)

     

1.065

0.587

< 10 cm

30

11

36.67

19

63.33

  

10–20 cm

58

22

37.93

36

62.07

  

> 20 cm

7

4

57.12%

3

42.88

  

Chemotherapy

     

14.194

0.0001

Chemoresistance

32

4

12.50

28

87.50

  

Chemosensitivity

63

33

52.38

30

47.62

  

Metastasis

     

0.1

0.752

Y

19

8

42.11

11

57.89

  

N

76

29

38.16

47

61.84